We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OPGN market cap is 6.93M. The company's latest EPS is USD -3.2448 and P/E is -0.21.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.5M | 4.31M | 4.31M | 2.61M | 3.42M |
| Operating Income | -12.27M | -22.72M | -23.1M | -27.63M | -30.75M |
| Net Income | -12.45M | -26.21M | -41.97M | -37.28M | -32.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.42M | 49.75M | 71.67M | 25.81M | 1.88M |
| Total Liabilities | 6.13M | 28.56M | 30.45M | 18.24M | 13.44M |
| Total Equity | 4.29M | 21.19M | 41.22M | 7.58M | -11.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.51M | -23.4M | -21.48M | -20.45M | -14.32M |
| Investing | -2.5M | -1.06M | -1.98M | -591k | -800k |
| Financing | 12.17M | 34.09M | 47.45M | -6.74M | 8.37M |
| Market Cap | 6.93M |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 2.03 |
| Price to Cash Ratio | 6.03 |
| Price to Book Ratio | -0.6 |
| Dividend Yield | - |
| Shares Outstanding | 10.07M |
| Average Volume (1 week) | 1.6k |
| Average Volume (1 Month) | 1.3k |
| 52 Week Change | -60.66% |
| 52 Week High | 2.57 |
| 52 Week Low | 0.5273 |
| Spread (Intraday) | 0.3 (30.29%) |
| Company Name | OpGen Inc (PK) |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.opgen.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
